Back to Search
Start Over
Personalisierte Medizin.
- Source :
- Trillium-Diagnostik; 2024, Vol. 22 Issue 3, p160-165, 6p
- Publication Year :
- 2024
-
Abstract
- The article discusses the use of circulating tumor DNA (ctDNA) in blood tests to improve the personalized treatment of colorectal cancer by providing more accurate prognosis and monitoring therapy response, especially in early-stage disease detection and post-operative care. It highlights the role of ctDNA in liquid biopsies and its potential for revolutionizing cancer management by predicting treatment outcomes and identifying minimal residual disease.
- Subjects :
- CIRCULATING tumor DNA
COLORECTAL cancer
BLOOD testing
BIOPSY
THERAPEUTICS
Subjects
Details
- Language :
- German
- ISSN :
- 21981310
- Volume :
- 22
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Trillium-Diagnostik
- Publication Type :
- Academic Journal
- Accession number :
- 179758418
- Full Text :
- https://doi.org/10.47184/td.2024.03.01